FDA approves JournaVX, a non-opioid pain relief option for adults
The FDA approved Vertex Pharmaceuticals' Journavx in January 2025, the first new type of non-opioid pain medication in decades, for short-term pain after surgery or injury, designed to avoid addiction risk.
← Back to stories
National24 articles from 20 sources across the spectrum· Updated 606d ago
18 across the spectrum · tap a section to jump
How each side is putting it
Left
8 viewpointsFDA approves drug from Boston-based company to treat pain without opioid effects
Center
8 viewpointsRan by 3 outlets· FOX 35 Orlando, FOX 5 DC, +1 more
Right
2 viewpointsFDA approves painkiller designed to eliminate the risk of addiction associated with opioids
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
3 articlesCenter
0 articlesNone
Right
0 articlesNone